Defunct Company
Total Trials
39
As Lead Sponsor
26
As Collaborator
13
Total Enrollment
17,034
NCT00380315
Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of AG1321001 in Chronic Cougher
Phase: Phase 3
Role: Lead Sponsor
Start: Mar 31, 2006
Completion: Jun 30, 2007
NCT00384774
A Placebo-Controlled Adaptive Treatment Assignment Study of Intravenous COL-144 in the Acute Treatment of Migraine
Phase: Phase 2
Role: Collaborator
Start: Nov 30, 2006
NCT00883051
Dose-ranging Study of Oral COL-144 in Acute Migraine Treatment
Start: Jul 31, 2009
Completion: Feb 28, 2010
NCT01400945
Efficacy Study of AGSPT201 Tablet to Treat Gastroesophageal Reflux Disease
Start: Dec 31, 2009
Completion: Sep 30, 2011
NCT01151202
"Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of AG NPP709 Syrup"
Start: Feb 28, 2010
Completion: Jun 30, 2010
NCT01416480
"Clinical Trial to Evaluate the Safety and Efficacy of Theobromine Capsule as an Antitussive in Acute Cougher"
Start: May 31, 2010
Completion: May 31, 2011
NCT01413048
Clinical Trial to Evaluate the Antihypertensive Effect of AGSCT101 in Patient With Hypertension
Start: Jan 31, 2011
Completion: Sep 30, 2012
NCT03465436
A Study of Lasmiditan on the Heart in Healthy Participants
Phase: Phase 1
Start: Sep 16, 2011
Completion: Dec 20, 2011
NCT01536353
Clinical Trial to Evaluate the Bioavailability and Safety of AGSAV301
Start: Jan 31, 2012
Completion: Aug 31, 2012
NCT01647893
Phase 1 Single Dose Escalation Study of CTB-001
Start: Jul 31, 2012
Completion: Dec 31, 2012
NCT01821521
Investigate a Pharmacokinetics Between S-pantoprazole 20mg and Pantoprazole 40mg in Healthy Male Subjects
Start: Jun 30, 2013
Completion: Not specified
NCT01982916
Clinical Trial to Evaluate the Safety and Efficacy of AGR Tablet as a Treatment of Perennial Allergic Rhinitis in Korean
Start: Dec 31, 2013
Completion: Jan 31, 2015
NCT02274961
S-pantoprazole 10mg Phase III Clinical Study
Start: Oct 31, 2014
NCT02233296
Food-Effect Study in Healthy Participants
Start: Jan 31, 2015
Completion: Mar 31, 2015
NCT02439320
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:
Start: Apr 30, 2015
Completion: Aug 31, 2016
NCT02565186
An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine
Start: Oct 7, 2015
Completion: Aug 20, 2019
NCT02609711
Investigate a Interaction of Candesartan and Atorvastatin in Healthy Male Sugjects
Start: Nov 30, 2015
NCT02605174
Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute Treatment of Migraine
Start: May 31, 2016
Completion: Jun 30, 2017
NCT03012334
The Effects of Lasmiditan on Simulated Driving Performance - Healthy Participants
Start: Jan 16, 2017
Completion: Jun 8, 2017
NCT03040479
Pharmacokinetic Single Dose Study of Oral Lasmiditan in Participants With Normal and Impaired Hepatic Function
Start: Mar 14, 2017
Completion: Jul 17, 2017
NCT03076970
Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan in Healthy Participants
Start: Mar 21, 2017
Completion: Apr 13, 2017
NCT03009162
Study of Oral Lasmiditan in Participants With Normal and Impaired Renal Function
Start: Apr 1, 2017
Completion: Jun 2, 2017
NCT03623282
Study Regarding the Clinical Efficacy of Synatura® in Patients With Chronic Bronchitis Type COPD
Phase: Phase 4
Start: Apr 17, 2017
Completion: May 2, 2018
NCT03040362
Absorption, Metabolism and Excretion of [14C]-Lasmiditan - Single Oral Dose Administration
Start: Apr 20, 2017
Completion: May 6, 2017
NCT04107740
C-Trelin Orally Disintegrated(OD) Tablet 5mg in Ataxia Due to Spinocerebellar Degeneration
Start: Mar 4, 2019
Completion: Feb 8, 2021
NCT03957603
Medical Nutrition Therapy Combined With TPF-DM in Pregnant Women With Gestational Diabetes Mellitus
Phase: N/A
Start: May 16, 2019
Completion: Dec 31, 2023
NCT05344638
"A Clinical Trial to Evaluate the Safety and Efficacy of AG1904 in Acute Bronchitis"
Start: Oct 17, 2019
Completion: Jul 29, 2020
NCT04554303
Comparing Safety and Efficacy of Amlodipine Verses S Amlodipine in Patients With Essential Hypertension
Start: Oct 28, 2020
Completion: May 23, 2022
NCT05206578
Study to Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia
Start: Dec 8, 2020
Completion: Sep 8, 2022
NCT04686643
Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension
Start: Feb 1, 2021
Completion: May 1, 2022
NCT05503953
Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension Inadequately Controlled With AGLS
Start: Sep 5, 2022
Completion: Jul 31, 2024
NCT06046066
A Phase 1 Study of NM6603 in Advanced Solid Tumors
Start: Aug 31, 2023
Completion: Feb 28, 2026
NCT06549504
Bioequivalence Study of AG2202
Start: Aug 31, 2024
Completion: Sep 30, 2024
NCT06717360
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2304T and AG2304R
Start: Jun 30, 2025
Completion: Jun 30, 2027
NCT07083206
A Study to Evaluate the Effectiveness and Safety of Fixed-Dose Combination of Pitavastatin/ Ezetimibe
Start: Jul 29, 2025
Completion: Jan 31, 2029
NCT06916169
A Study to Evaluate the Safety and Pharmacokinetics of AG2304 Compared to Coadministration of AG23041 and AG23042
Start: Aug 31, 2025
Completion: Sep 30, 2025
NCT07198347
Efficacy and Safety of AG2001 in Patients With Acute Bronchitis
Start: Nov 1, 2025
Completion: Oct 31, 2026